(±)-Clopidogrel-d7 sulfate 10678 At the moment Phase III

At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)

GSK3186899 is also more active in a panel of Leishmania lines using human peripheral blood mononuclear cells as the host cells

IC50: 34 and 304 nM in the presence of 10 and 100 μM ATP

Formula: C27H29N7

8 hours) induces dose-dependent cytotoxicity

(±)-Clopidogrel-d7 sulfate 10678 At the moment Phase IIIProduct information CAS Number: 1346598 07 9 Molecular Weight: 426. 94 Formula: C16H18ClNO6S2 Chemical Name: (H)methyl 2 [2 chloro(3,4,5,6 H)phenyl] 2 {4H,5H,6H,7H thieno[3,2 c]pyridin 5 yl}acetate; sulfuric acid Smiles: [2H]C1=C(Cl)C(C(C(=O)OC([2H])([2H])[2H])N2CC3C=CSC=3CC2)=C([2H])C([2H])=C1[2H]. OS(O)(=O)=O InChiKey: FDEODCTUSIWGLK ANHTTWOXSA N InChi: InChI=1S C16H16ClNO2S. H2O4S c1 20 16(19)15(12 4 2 3 5 13(12)17)18 8 6 14 11(10 18)7 9 21 14; 1